Should the Trail Blazers be worried about Ja Morant's latest injury?

The Portland Trail Blazers have reasons to be encouraged by their early-season start, but Ja Morant's latest injury presents an immediate test for a team hoping to turn its backcourt talent into sustained success. Morant will miss four weeks after suffering a Grade 2 strain of his left hamstring, the Trail Blazers announced.

The injury occurred Thursday night against the Memphis Grizzlies , the team that traded the guard to Portland in the offseason. Morant scored 14 points in 23 minutes before the injury overshadowed a game in which the Trail Blazers suffered their first loss of the season.

The timing is frustrating for Portland. Morant had shown encouraging signs in his first four games with the franchise, averaging 15.8 points and 5.5 assists while shooting 54.2% from the field and 42.9% from 3-point range.

Those numbers suggested he was finding his footing in a new setting and beginning to establish a role alongside the team's other backcourt options. Now, the Trail Blazers must adjust without him for at least the next month. Should Portland be concerned? Yes, particularly about Morant's availability over the long term, rather than the immediate impact of a four-week absence.

A Grade 2 hamstring strain is a significant setback, and the re-evaluation timeline does not guarantee Morant will be ready to return immediately afterward. The team will have to manage his recovery carefully, especially given his history of injuries and the limited number of games he played last season.

Morant's injury history raises the stakes

The latest setback is concerning because it adds another chapter to a series of injury interruptions in Morant's recent seasons . The 27-year-old appeared in just 20 games during the 2025-26 campaign because of an elbow sprain, limiting his opportunity to build rhythm and remain consistently available.

Now, a hamstring injury threatens to disrupt another season before it has fully developed. Missing four weeks can make it difficult to maintain conditioning and continuity. For a guard whose game depends heavily on acceleration, changes of direction and attacking defenders off the dribble, hamstring health is especially important. Portland will have to be cautious about bringing Morant back before he is ready, even if the team is eager to restore its full rotation.

The distinction between a four-week re-evaluation and a firm return date matters. The former means the Trail Blazers will assess his progress at that point; it does not establish that he will immediately resume playing. His recovery, response to rehabilitation and ability to handle basketball activity will determine the next step. Portland should resist the temptation to treat the announced timeline as a deadline.

The bigger concern is availability, not talent

Morant's ability to influence a game is not the central issue. His strong start in Portland showed that he can still be an efficient scorer while contributing as a playmaker. The concern is whether he can remain healthy enough to build on those flashes and develop consistent chemistry with his new teammates.

That question carries particular weight after a season in which he played only 20 games. Another extended absence would mean more missed opportunities to learn the offense, establish reliable rotations and develop the kind of continuity that teams need as the season progresses. It also creates uncertainty for Portland's long-term planning.

A talented backcourt can give a team a high ceiling, but the potential of that group depends on its key players being available together. Every extended absence makes it harder to evaluate how effective the lineup can be when fully healthy.

Still, it would be premature to draw sweeping conclusions from this injury alone. A hamstring strain does not automatically mean Morant will continue to experience recurring problems, and his recovery will provide a clearer indication of how quickly he can return to form.

The Trail Blazers' immediate priority should be protecting Morant's recovery while keeping the team competitive. His four-week re-evaluation will be an important checkpoint, but the organization should focus on his readiness rather than rushing to meet a particular date.